Single cell omics solutions. Genomics/Transcriptomics/Epigenomics/Proteomics/Metabolomics. Comprehensive Single Cell Analysis Service for Oncology/SARS-CoV-2/Immunity and Microbiome
- sc Death Analysis
Death Analysis for Single Cell
Customized SPARKL Services
- sc Protein Analysis
Protein Analysis for Single Cell
ELISA/CE/WB/Microfluidics
- sc Death Analysis
Suchergebnisse
Suchergebnisse:
Ovarian borderline tumors, also known as low malignant potential (LMP) ovarian tumors, do not cause an increase in CA125 levels and are not identifiable with an ultrasound. The typical symptoms of an LMP tumor can include abdominal distension or pelvic pain. Particularly large masses tend to be benign or borderline.
It was approved in 2014. Nivolumab is approved to treat melanoma, lung cancer, kidney cancer, bladder cancer, head and neck cancer, and Hodgkin's lymphoma. A 2016 clinical trial for non-small cell lung cancer failed to meet its primary endpoint for treatment in the first line setting, but is FDA approved in subsequent lines of therapy.
The kidneys are made up of different types of cells. The type of cancer you have depends on the type of cell the cancer started in. The most common type of kidney cancer is renal cell cancer (RCC). It starts in the cells lining the tubules (the smallest tubes) inside the nephrons. The main type of renal cell cancer is clear cell cancer.
Multiple myeloma ( MM ), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. [6] Often, no symptoms are noticed initially. [10] As it progresses, bone pain, anemia, kidney dysfunction, and infections may occur. [10]
25. März 2022 · किडनी कैंसर के जोखिम कारक (Risk factors for kidney cancer in Hindi) कई मामलों में, किडनी कैंसर के कारणों का पता नहीं चल पाया है। लेकिन, कुछ कारक है, जो किडनी कैंसर होने के जोखिम को ...
गुर्दे का कैंसर. Micrograph गुर्दे के कैंसर का सबसे सामान्य प्रकार (clear cell renal cell carcinoma ). H&E stain. किडनी कैंसर, जिसे गुर्दे के कैंसर के रूप में भी जाना ...
1. Okt. 2018 · Abstract. Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approaches for renal cancer.
